RU2020135965A - Композиция для перорального применения в виде жевательной резинки и способ ее получения - Google Patents

Композиция для перорального применения в виде жевательной резинки и способ ее получения Download PDF

Info

Publication number
RU2020135965A
RU2020135965A RU2020135965A RU2020135965A RU2020135965A RU 2020135965 A RU2020135965 A RU 2020135965A RU 2020135965 A RU2020135965 A RU 2020135965A RU 2020135965 A RU2020135965 A RU 2020135965A RU 2020135965 A RU2020135965 A RU 2020135965A
Authority
RU
Russia
Prior art keywords
amount
weight
chewing gum
pharmaceutical composition
water
Prior art date
Application number
RU2020135965A
Other languages
English (en)
Russian (ru)
Inventor
Режин ДЕТАЛЛЬ
Оливье ПИАР
Лоран СЛИПЕЦКИ
Перлин ПУРАНТРЮ
Катрин БЛАНДЕН
Аиша ШЕККАЛЬ
Элоди ЛАЛУЕ
Original Assignee
Санофи Уинтроп Эндюстри
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи Уинтроп Эндюстри filed Critical Санофи Уинтроп Эндюстри
Publication of RU2020135965A publication Critical patent/RU2020135965A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2020135965A 2018-04-03 2019-03-29 Композиция для перорального применения в виде жевательной резинки и способ ее получения RU2020135965A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305393.3 2018-04-03
EP18305393.3A EP3549579A1 (en) 2018-04-03 2018-04-03 Oral gum formulation and fabrication process thereof
PCT/EP2019/058109 WO2019192942A1 (en) 2018-04-03 2019-03-29 Oral gum formulation and fabrication process thereof

Publications (1)

Publication Number Publication Date
RU2020135965A true RU2020135965A (ru) 2022-05-04

Family

ID=61965891

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020135965A RU2020135965A (ru) 2018-04-03 2019-03-29 Композиция для перорального применения в виде жевательной резинки и способ ее получения

Country Status (7)

Country Link
US (1) US20210093562A1 (https=)
EP (2) EP3549579A1 (https=)
JP (1) JP2021520408A (https=)
BR (1) BR112020019761A2 (https=)
MX (1) MX2020010400A (https=)
RU (1) RU2020135965A (https=)
WO (1) WO2019192942A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210307353A1 (en) * 2018-07-26 2021-10-07 Wm. Wrigley Jr. Company Process for reducing tempering time for deposited confectionery products
EP4255399A4 (en) * 2020-12-01 2024-12-18 Seattle Gummy Company Ped5 inhibitor semi-solid compositions and methods of making and using thereof
US20250066092A1 (en) * 2023-08-25 2025-02-27 Day Dreamers Confections Direct-Mold Blister Packaging System for Chocolate and Gummy Products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897566A (en) * 1973-12-06 1975-07-29 Gen Foods Corp Chewing gums having longer lasting sweetness and flavor
US4780324A (en) * 1987-06-23 1988-10-25 Warner-Lambert Company Chewing gum with long lasting softness
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
US6235318B1 (en) * 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
JP4783370B2 (ja) * 2004-08-25 2011-09-28 キャドバリー・アダムズ・ユーエスエイ・エルエルシー 液体充填チューインガム組成物
US20100136164A1 (en) * 2004-08-25 2010-06-03 Cadbury Adams Usa Llc Package assembly for multi-modality taste chewing gum compositions
JP2009159843A (ja) * 2007-12-28 2009-07-23 Uha Mikakuto Co Ltd チューインガムとその製造方法
CN101628117B (zh) * 2009-08-18 2011-02-16 北京航洋胶囊技术有限公司 一种咀嚼软胶囊皮、咀嚼软胶囊药物及其制备方法
JP6346623B2 (ja) 2013-02-14 2018-06-20 サノフイ 経口投与用の咀嚼可能な組成物およびその製造方法
CA2864531A1 (en) * 2014-02-06 2015-08-06 RAP Nutrition LLC High protein gummy product and process of making
US20160067180A1 (en) 2014-09-05 2016-03-10 Santa Cruz Pharmaceuticals, Inc. Semi-solid chewable dosage form for over-the-counter medications and method for producing same
ES2787220T3 (es) * 2015-03-26 2020-10-15 Patheon Softgels Inc Cápsulas blandas llenas de líquido
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation

Also Published As

Publication number Publication date
EP3549579A1 (en) 2019-10-09
WO2019192942A1 (en) 2019-10-10
JP2021520408A (ja) 2021-08-19
MX2020010400A (es) 2021-02-09
EP3773470A1 (en) 2021-02-17
US20210093562A1 (en) 2021-04-01
BR112020019761A2 (pt) 2021-01-26

Similar Documents

Publication Publication Date Title
RU2020135965A (ru) Композиция для перорального применения в виде жевательной резинки и способ ее получения
JP2018184458A5 (https=)
US20080057115A1 (en) Capsule Stable Against Mastication
CA2633924A1 (en) Gastric reflux resistant dosage forms
JP5715400B2 (ja) ロキソプロフェン含有医薬組成物
TW201343203A (zh) 含有ω－３脂肪酸之經明膠／藻酸鹽延緩釋放型膠囊，其製法及用途
JP2021520408A5 (https=)
HRP20180129T1 (hr) Oralno raspadajuća čvrsta jedinica doze koja sadrži estetrol komponentu
JP7303221B2 (ja) 腸溶性ソフトゲルカプセル剤
RU2017129161A (ru) Композиции липидов
CN104288120A (zh) 肠溶植物纤维素硬空心胶囊及其制备方法
JP7443266B2 (ja) 腸溶性ソフトゲルカプセル剤
US20130231310A1 (en) Mesalamine suppository
EP2827839A1 (en) Gelling agent-based dosage form
CN1878542A (zh) 非片剂化的、可咀嚼的单独剂量给药剂型
JP2007510690A5 (https=)
TWI622408B (zh) 用於口服之可嚼組合物及其製備方法
JP7443507B2 (ja) ガムタイプの少なくとも１つの医薬品又は食品サプリメント製品のためのブリスターパッケージ
RU2014113580A (ru) Применение детской молочной смеси с крупными липидными глобулами
KR100732199B1 (ko) 저작성 캡슐 및 그 제조 방법
RU2015143993A (ru) Твердые лекарственные формы, обладающие противорвотным действием, с замедленным высвобождением
JPWO2019192942A5 (https=)
JP2011507853A5 (https=)
US9314435B2 (en) Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
WO2011128634A2 (en) Over the counter pharmaceutical compositions